At what enterprise value was HIPPOCRATES (LAF - LA FARMACIA) acquired in 2020?

During the acquisition of HIPPOCRATES (LAF - LA FARMACIA) by ANTIN INFRASTRUCTURE in 2020, the transaction's Enterprise Value is estimated to be in the range of 500M - 1.5b EUR.

What was the EV/EBITDA of HIPPOCRATES (LAF - LA FARMACIA) when it was acquired by ANTIN INFRASTRUCTURE?

The estimated EV/EBITDA multiple for HIPPOCRATES (LAF - LA FARMACIA) is in the range of 15x - 25x.

What was the revenue of HIPPOCRATES (LAF - LA FARMACIA) at the time of the deal?

The revenue of HIPPOCRATES (LAF - LA FARMACIA) at the time of the deal is estimated to be in the range of 150M - 250M EUR.

What was the EBITDA of HIPPOCRATES (LAF - LA FARMACIA) during the acquisition?

HIPPOCRATES (LAF - LA FARMACIA)'s EBITDA is estimated to be in the range of 25M - 50M EUR.

How is the data for the HIPPOCRATES (LAF - LA FARMACIA) acquisition sourced and is it reliable?

Mynth data is contributed by a professional community of M&A and Private Equity experts. Each transaction, including the HIPPOCRATES (LAF - LA FARMACIA) deal, is systematically cross-verified by our team using private deal documents and official sources. You can also find the official press release for this transaction here: https://www.antin-ip.com/media/our-news/hippocrates-welcomes-antin-infrastructure-partners-long-term-strategic-partner

← DATABASE

Home Database Healthcare & PharmaHIPPOCRATES (LAF - LA FARMACIA)

12/2020

HIPPOCRATES (LAF - LA FARMACIA) acquired by ANTIN INFRASTRUCTURE

ITALY Health Providers / Outpatient Care / Pharmacy EV 500M - 1.5b EUR

Context

Antin Infrastructure Partners acquired a majority stake (approximately 80%) in Hippocrates Holding. The co-founders reinvested to retain the remaining 20% and maintained their roles as co-CEOs. The original investors (including DVR Capital and Italian family offices such as the Notarbartolo and Marzotto families) sold their shares in this transaction. The transaction was intended to provide the capital needed to accelerate the consolidation strategy in the highly fragmented Italian pharmacy market.

HIPPOCRATES (LAF - LA FARMACIA), which reported an EBITDA margin of in 2020, is valued in this transaction at an EV/EBITDA multiple of , representing a to the average currently observed in the Healthcare & Pharma sector (15.6x).

-> Deep-dive in Healthcare & Pharma market trends

Target

Hippocrates Holding is the leading independent pharmacy network in Italy. Founded in 2018 by Davide Tavaniello and Rodolfo Guarino, the group operates 615 pharmacies under the proprietary brand "LaF" (La Farmacia). It aggregates independent pharmacies into a centrally managed corporate network, offering Corporate efficiencies and standardized services.

Ent. Value

Equity Value

Multiples

EV / Revenue

EV / EBITDA

EV / EBIT

Historical Financials (EUR)

Year

Rev

EBITDA

EBIT

2020

2019

Similar deals in Health Providers

List of similar M&A transactions (Date, Acquirer, Target, Country, Sub-sector)
Date	Acquirer	Target	Country	Sector
03/2021	TRITON PARTNERS	BERGMAN CLINICS	NETHERLANDS	Clinics / Hospitals
02/2021	SILVER LAKE / NESTLE	IVC EVIDENSIA	UNITED KINGDOM	Vet Clinics
12/2020	RADIOLOGY PARTNERS	MEDNAX RADIOLOGY SOLUTIONS	UNITED STATES	Radiology
12/2020	FRESENIUS	EUGIN GROUP	SPAIN	Outpatient Care
12/2020	MEDIAN KLINIKEN	PRIORY GROUP	UNITED KINGDOM	Clinics / Hospitals
11/2020	ARDIAN	INOVIE GROUP	FRANCE	Labs (Biology)
11/2020	DWS GROUP	MEDIPASS	ITALY	Radiology
11/2020	L CATTERTON	ALLIANCE ANIMAL HEALTH	UNITED STATES	Vet Clinics
11/2020	APHEON (EX ERGON)	VIDACURA	GERMANY	Nursing Homes
11/2020	MEDICA GROUP	GLOBAL DIAGNOSTICS	IRELAND	Radiology

REFERENCES

Valuation range: EV 500M - 1.5b EUR

Revenue range: 150M - 250M EUR

EBITDA range: 25M - 50M EUR

Note: This page provides detailed data on a private equity M&A transaction. Detailed and exact financial metrics for the acquisition of HIPPOCRATES (LAF - LA FARMACIA) by ANTIN INFRASTRUCTURE are reserved for mynth community members. Register for free to unlock full data.

Authors: This transaction was contributed by a verified mynth contributor and cross-checked against available transaction documents and official company communications.

Press release: view release

Target: hippocrates (laf - la farmacia)

Acquirer: antin infrastructure